Clomiphene ovulation induction and higher-order multiple pregnancy.
Simon McDowell, Ben Kroon, Anusch Yazdani
Index: Aust. N. Z. J. Obstet. Gynaecol. 53(4) , 395-8, (2013)
Full Text: HTML
Abstract
Clomiphene citrate is a widely used treatment for ovulatory dysfunction in women seeking pregnancy. The major adverse consequence of clomiphene use is the increased risk of multiple and higher-order multiple pregnancy. Mechanisms for multiple pregnancy include dosing variation, adjuvant therapies, pretreatment weight loss and a cumulative effect of multiple clomiphene cycles. It has been suggested that the risk of higher-order multiple pregnancy may be reduced with ultrasound monitoring, although there is limited evidence to support this practice. © 2013 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Related Compounds
Related Articles:
2014-04-01
[J. Urol. 191(4) , 1072-6, (2014)]
2013-11-01
[Fertil. Steril. 100(5) , 1373-80, (2013)]
2013-12-01
[J. Urol. 190(6) , 2209, (2013)]
Evaluation of the genotoxicity of clomiphene citrate.
2014-01-01
[Mutat. Res. Genet. Toxicol. Environ. Mutagen. 759 , 21-7, (2014)]
2013-01-01
[Front. Horm. Res. 40 , 128-41, (2013)]